Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: A report from EUROASPIRE IV - A survey from the European Society of Cardiology

European Heart Journal

Volumn 36, Issue 19, 2015, Pages 1171-1177c

  Gyberg, Viveca ^a,b   De Bacquer, Dirk ^c,d   Kotseva, Kornelia ^c,e   De Backer, Guy ^c,d   Schnell, Oliver ^f   Sundvall, Jouko ^c,g   Tuomilehto, Jaakko ^c,g,h,i,j   Wood, David ^e   Rydén, Lars ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c les Templiers   (France)

^d GHENT UNIVERSITY   (Belgium)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h DANUBE UNIVERSITY KREMS   (Austria)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^j KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

more..

Author keywords

Coronary artery disease; Diabetes; HbA1c; Impaired fasting glucose; Impaired glucose tolerance; Oral glucose tolerance test

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; BODY MASS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSGLYCEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SELF REPORT; ADOLESCENT; BLOOD; CLINICAL TRIAL; COMPLICATION; DIABETIC ANGIOPATHY; DIET RESTRICTION; EARLY DIAGNOSIS; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; INCIDENTAL FINDING; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; EARLY DIAGNOSIS; FASTING; FEMALE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84929895790     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv008     Document Type: Review

References (38)

1. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler-Soler J, Ohrvik J. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004;25:1880-1890.
2. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-2144.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69.
4. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Z, Sattar N, Schachinger V, Scheen A, Schirmer H, Stromberg A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013.
5. World HealthOrganisation (WHO) Consultation. Definitionand diagnosis of diabetes and intermidiate hyperglycemia. 2006 http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes-new.pdf (16 April 2014).
6. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, Knowler WC. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994;308:1323-1328.
7. International Expert Committee reporton the roleof the A1C assayin the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334.
8. World Health Organization (WHO), Abbreviated report of a WHO consultation. Use of glycated hemoglobin (HbA1c) in the diagnosis if diabetes mellitus. 2011. http://www.who.int/diabetes/publications/diagnosis-diabetes2011/en/index.html (13 April 2014).
9. Barrett-Connor E. The oral glucose tolerance test, revisited. Eur Heart J 2002;23: 1229-1231.
10. Bonora E, Tuomilehto J. The pros and consofdiagnosing diabetes with A1C. Diabetes Care 2011;34(Suppl. 2):S184-S190.
11. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009;373:929-940.
12. Anselmino M, Bartnik M, Malmberg K, Ryden L. Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the Heart. Eur J Cardiovasc Prev Rehabil 2007;14:28-36.
13. Hannestad U, Lundblad A. Accurate and precise isotope dilution mass spectrometry method for determining glucose in whole blood. Clin Chem 1997;43:794-800.
14. Carstensen B, Lindstrom J, Sundvall J, Borch-Johnsen K, Tuomilehto J. Measurement of blood glucose: comparison between different types of specimens. Ann Clin Biochem 2008;45(Pt 2):140-148.
15. Hage C, Lundman P, Ryden L, Mellbin L. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes. Eur J Prev Cardiol 2013;20:549-554.
16. Farhan S, Jarai R, Tentzeris I, Kautzky-Willer A, Samaha E, Smetana P, Jakl-Kotauschek G, Wojta J, Huber K. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease. Clin Res Cardiol 2012;101:625-630.
17. Doerr R, Hoffmann U, Otter W, Heinemann L, Hunger-Battefeld W, Kulzer B, Klinge A, Lodwig V, Amann-Zalan I, Sturm D, Tschoepe D, Spitzer SG, Stumpf J, Lohmann T, Schnell O. Oral glucose tolerance test and HbA(1)cfor diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study. Diabetologia 2011;54:2923-2930.
18. de laHera JM, Garcia-Ruiz JM, Martinez-Camblor P, Martin M, Telleria AL, Corros C, Torres F, Fernandez-Cimadevilla OC, Alvarez-Pichel I, Capin E, Avanzas P, Delgado E. Real incidence of diabetes mellitus in a coronary disease population. Am J Cardiol 2013;111:333-338.
19. Bartnik M, Ryden L, Malmberg K, Ohrvik J, Pyorala K, Standl E, Ferrari R, Simoons M, Soler-Soler J. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart 2007;93:72-77.
20. International Diabetes Federation. Diabetes Atlas, 6th edn. Brussels, Belgium: International Diabetes Federation; 2013.
21. Malkani S, Mordes JP. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med 2011;124:395-401.
22. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010;33:562-568.
23. Cosson E, Nguyen MT, Hamo-Tchatchouang E, Banu I, Chiheb S, Charnaux N, Valensi P. What wouldbethe outcomeifthe American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006? Diabet Med 2011;28:567-574.
24. Mostafa SA, Davies MJ, Webb D, Gray LJ, Srinivasan BT, Jarvis J, Khunti K. The potential impactofusing glycated haemoglobinasthe preferred diagnostic tool for detecting Type 2 diabetes mellitus. Diabet Med 2010;27:762-769.
25. Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010;33:2104-2109.
26. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM. Diabetes and mortality following acute coronary syndromes. JAMA 2007;298:765-775.
27. Lenzen M, Ryden L, Ohrvik J, Bartnik M, Malmberg K, ScholteOpReimer W, Simoons ML. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J 2006;27:2969-2974.
28. Sourij H, Saely CH, Schmid F, Zweiker R, Marte T, Wascher TC, Drexel H. Postchallenge hyperglycaemia is strongly associated with future macrovascular events and total mortalityinangiographiedcoronary patients. Eur HeartJ2010;31:1583-1590.
29. The DECODE (Diabetes Epidemiology: Collaborative analysisofDiagnostic Criteria in Europe)-study group. European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabe-tologia 1999;42:647-654.
30. Ning F, Tuomilehto J, Pyorala K, Onat A, Soderberg S, Qiao Q. Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care 2010;33:2211-2216.
31. Marini MA, Succurro E, Castaldo E, Cufone S, Arturi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care 2012;35:1144-1149.
32. Preiss D, Welsh P, Murray HM, Shepherd J, Packard C, Macfarlane P, Cobbe S, Ford I, Sattar N. Fasting plasma glucose innon-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J 2010;31:1230-1236.
33. Anselmino M, Malmberg K, Ohrvik J, Ryden L. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur J Cardiovasc Prev Rehabil 2008;15:216-223.
34. Wang JS, Lee IT, Lee WJ, Lin SY, Fu CP, Ting CT, Lee WL, Liang KW, Sheu WH. Performance of HbA1c and fasting plasma glucose in screening for diabetes in patients undergoing coronary angiography. Diabetes Care 2013;36:1138-1140.
35. National Institute for Health and Clinical Excellence (NICE). Hyperglycaemia in Acute Coronary Syndromes. Management of Hyperglycaemia in Acute coronary Syndromes. London, UK: National Institute for Health and Clinical Excellence (NICE); 2011. p130 (Clinical guideline).
36. Drozda J Jr, Messer JV, Spertus J, Abramowitz B, Alexander K, Beam CT, Bonow RO, Burkiewicz JS, Crouch M, Goff DC Jr, Hellman R, James T 3rd, King ML, Machado EA Jr, Ortiz E, O'Toole M, Persell SD, Pines JM, Rybicki FJ, Sadwin LB, Sikkema JD, Smith PK, Torcson PJ, Wong JB. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation 2011;124:248-270.
37. Wallander M, Malmberg K, Norhammar A, Ryden L, Tenerz A. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care 2008;31:36-38.
38. Ferrari R. EURObeservational Research Programme. Eur Heart J 2010;31: 1023-1031.